This provider's $13.8M in total Medicare payments ranks in the 99th percentile of Nuclear Medicine providers nationally.
Medicare payments to this provider grew 663% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 378% in 2023
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $886.49 | $208.99 | 4.24x | $677.50 | $534.2K | 2.6K | 18 |
| 2015 | $418.12 | $110.79 | 3.77x | $307.33 | $869.9K | 7.9K | 32 |
| 2016 | $383.72 | $103.58 | 3.70x | $280.14 | $1.5M | 14.6K | 34 |
| 2017 | $649.39 | $200.73 | 3.24x | $448.66 | $1.2M | 6.2K | 25 |
| 2018 | $677.42 | $195.85 | 3.46x | $481.57 | $1.5M | 7.6K | 28 |
| 2019 | $981.69 | $301.04 | 3.26x | $680.65 | $1.2M | 4.1K | 31 |
| 2020 | $981.21 | $334.27 | 2.94x | $646.94 | $1.2M | 3.5K | 31 |
| 2021 | $873.58 | $244.85 | 3.57x | $628.73 | $804.1K | 3.3K | 31 |
| 2022 | $711.40 | $188.74 | 3.77x | $522.66 | $852.5K | 4.5K | 34 |
| 2023 | $687.34 | $252.87 | 2.72x | $434.47 | $4.1M | 16.1K | 45 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 3.3K | $4.2M | $1.3K | 3.09x |
| A9606 | Radium ra-223 dichloride, therapeutic, per microcurie | 19.4K | $2.0M | $103.19 | 3.69x |
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 8.0K | $1.5M | $190.00 | 1.28x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 1.8K | $859.3K | $483.30 | 3.09x |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | 8.5K | $846.9K | $99.08 | 4.87x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 3.4K | $742.2K | $219.52 | 3.08x |
| 78816 | Nuclear medicine study whole body with ct scan | 471 | $598.5K | $1.3K | 3.17x |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 256 | $565.9K | $2.2K | 2.39x |
| A9699 | Radiopharmaceutical, therapeutic, not otherwise classified | 34 | $349.8K | $10.3K | 3.89x |
| 78306 | Nuclear medicine study of bone and/or joint whole body | 2.0K | $242.5K | $122.68 | 3.10x |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | 792 | $241.6K | $305.01 | 3.49x |
| J2785 | Injection, regadenoson, 0.1 mg | 3.4K | $146.4K | $43.25 | 2.78x |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 2.1K | $138.9K | $66.51 | 8.65x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 370 | $128.7K | $347.93 | 1.32x |
| A9520 | Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries | 287 | $120.6K | $420.36 | 2.68x |
| 78072 | Nuclear medicine study of parathyroid with spect and ct scan | 379 | $94.1K | $248.37 | 4.35x |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 352 | $93.4K | $265.47 | 3.02x |
| 78315 | Nuclear medicine study of bone taken at different times | 416 | $74.1K | $178.04 | 2.98x |
| 78582 | Nuclear medicine study of lung ventilation and circulation | 1.4K | $71.8K | $51.54 | 4.33x |
| 78320 | Nuclear medicine study of bone and/or joint | 761 | $67.7K | $89.01 | 5.66x |
This provider submits charges 3.26 times higher than what Medicare actually pays.
A markup ratio of 3.26x means for every $100 Medicare pays, this provider initially charges $326. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data